Evidence map›Paper›PMID 36496485›Full record

ArticleCommunications biology2022

Electrodeposited magnetic nanoporous membrane for high-yield and high-throughput immunocapture of extracellular vesicles and lipoproteins.

Chenguang Zhang, Xiaoye Huo, Yini Zhu, James N Higginbotham, Zheng Cao, Xin Lu, Jeffrey L Franklin, Kasey C Vickers, Robert J Coffey, Satyajyoti Senapati and 2 more

Abstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Chenguang Zhang *Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.ORCID http://orcid.org/0000-0001-5124-875X
Xiaoye Huo *Department of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.
Yini ZhuDepartment of Biology, University of Notre Dame, Notre Dame, IN, 46556, USA.
James N HigginbothamDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Zheng CaoDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Xin LuDepartment of Biology, University of Notre Dame, Notre Dame, IN, 46556, USA.ORCID http://orcid.org/0000-0002-0284-6478
Jeffrey L FranklinDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Kasey C VickersDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Robert J CoffeyDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.
Satyajyoti SenapatiDepartment of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA.
Ceming WangAopia Biosciences, 31351 Medallion Dr, Hayward, CA, 94544, USA. cwang9@nd.edu.ORCID http://orcid.org/0000-0002-1328-6410
Hsueh-Chia ChangDepartment of Chemical and Biomolecular Engineering, University of Notre Dame, Notre Dame, IN, 46556, USA. hchang@nd.edu.ORCID http://orcid.org/0000-0003-2147-9260

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Non-coding RNA & Bioinformatics CoreP01HL116263 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LINTON, MACRAE F · 2014 to 2025
$24.7M
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal CancerP50CA236733 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Robert J. Coffey · 2019 to 2026
$19.6M
Roles for Supermeres in CRC ProgressionP01CA229123 · NCI · VANDERBILT UNIVERSITY · PI Alissa M Weaver · 2020 to 2026
$12.9M
Integrated approach to study early and late events in colonic neoplasia: mouse to manR35CA197570 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Robert J. Coffey · 2017 to 2026
$9.4M
High-Throughput Electrokinetic Fractionation and Analysis of Extracellular RNA Nano-CarriersUH3CA241684 · NCI · UNIVERSITY OF NOTRE DAME · PI CHANG, HSUEH-CHIA · 2021 to 2022
$1.9M
High-Throughput Electrokinetic Fractionation and Analysis of Extracellular RNA Nano-CarriersUG3CA241684 · NCI · UNIVERSITY OF NOTRE DAME · PI CHANG, HSUEH-CHIA · 2019 to 2020
$927k
American Heart Association-American Stroke Association 971070NCI NIH HHS P01 CA229123NCI NIH HHS P50 CA236733NCI NIH HHS R35 CA197570NCI NIH HHS UG3 CA241684NCI NIH HHS UH3 CA241684NHLBI NIH HHS P01 HL116263NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

Superparamagnetic nanobeads offer several advantages over microbeads for immunocapture of nanocarriers (extracellular vesicles, lipoproteins, and viruses) in a bioassay: high-yield capture, reduction in incubation time, and higher capture capacity. However, nanobeads are difficult to "pull-down" because their superparamagnetic feature requires high nanoscale magnetic field gradients. Here, an electrodeposited track-etched membrane is shown to produce a unique superparamagnetic nano-edge ring with multiple edges around nanopores. With a uniform external magnetic field, the induced monopole and dipole of this nano edge junction combine to produce a 10× higher nanobead trapping force. A dense nanobead suspension can be filtered through the magnetic nanoporous membrane (MNM) at high throughput with a 99% bead capture rate. The yield of specific nanocarriers in heterogeneous media by nanobeads/MNM exceeds 80%. Reproducibility, low loss, and concentration-independent capture rates are also demonstrated. This MNM material hence expands the application of nanobead immunocapture to physiological samples.

Indexed as

Extracellular VesiclesMagnetic FieldsMembranesReproducibility of Results

Identifiers

PMID36496485
PMCPMC9741596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.